PTC Therapeutics Inc banner

PTC Therapeutics Inc
F:P91

Watchlist Manager
PTC Therapeutics Inc Logo
PTC Therapeutics Inc
F:P91
Watchlist
Price: 43.8 EUR 1.86% Market Closed
Market Cap: €3.1B

Wall St Price Targets

P91 Price Targets Summary
PTC Therapeutics Inc

Wall Street analysts forecast P91 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for P91 is 49.08 EUR with a low forecast of 34.74 EUR and a high forecast of 68.9 EUR.

Lowest Forecast
Price Target
34.74 EUR
21% Downside
Average Forecast
Price Target
49.08 EUR
12% Upside
Highest Forecast
Price Target
68.9 EUR
57% Upside
PTC Therapeutics Inc Competitors:
Price Targets
LGI
Lgi Ltd
50% Upside
AYTU
Aytu Biopharma Inc
323% Upside

Revenue
Forecast

35% / Year
Past Growth
-2% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
35% / Year
Past Growth
-2% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 3 years is -2%.

Gross Profit
Forecast

N/A
Past Growth
-5% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
-5% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

The compound annual growth rate for Gross Profit over the next 3 years is -5%.

Operating Income
Forecast

N/A
Past Growth
-12% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
-12% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

The compound annual growth rate for Operating Income over the next 3 years is -12%.

Pre-Tax Income
Forecast

N/A
Past Growth
-20% / Year
Estimated Growth
Estimates Accuracy
15%
Average Beat
N/A
Past Growth
-20% / Year
Estimated Growth
Estimates Accuracy
15%
Average Beat

The compound annual growth rate for Pre-Tax Income over the next 3 years is -20%.

Net Income
Forecast

70% / Year
Past Growth
-20% / Year
Estimated Growth
Estimates Accuracy
10%
Average Beat
70% / Year
Past Growth
-20% / Year
Estimated Growth
Estimates Accuracy
10%
Average Beat

Over the last 13 years, the compound annual growth rate for Net Income has been 70%. The projected CAGR for the next 3 years is -20%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is P91's stock price target?
Price Target
49.08 EUR

According to Wall Street analysts, the average 1-year price target for P91 is 49.08 EUR with a low forecast of 34.74 EUR and a high forecast of 68.9 EUR.

What is the Revenue forecast for PTC Therapeutics Inc?
Projected CAGR
-2%

Over the last 13 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 3 years is -2%.

What is the Gross Profit forecast for PTC Therapeutics Inc?
Projected CAGR
-5%

The compound annual growth rate for Gross Profit over the next 3 years is -5%.

What is the Operating Income forecast for PTC Therapeutics Inc?
Projected CAGR
-12%

The compound annual growth rate for Operating Income over the next 3 years is -12%.

What is the Pre-Tax Income forecast for PTC Therapeutics Inc?
Projected CAGR
-20%

The compound annual growth rate for Pre-Tax Income over the next 3 years is -20%.

What is the Net Income forecast for PTC Therapeutics Inc?
Projected CAGR
-20%

Over the last 13 years, the compound annual growth rate for Net Income has been 70%. The projected CAGR for the next 3 years is -20%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett